Pfizer COVID-19 Antiviral Pill Effective Against Omicron

  • by:
  • 08/19/2022

Pfizer announced Tuesday that its COVID-19 pill, Paxlovid, is effective against the omicron variant. 

The company said three separate lab studies showed the main protease inhibitor in the drug, nirmatrelvir, maintains its effectiveness against the omicron variant. 

As reported by The Hill, patients take two tablets of nirmatrelvir with one tablet of another antiviral, ritonavir, twice  a day for five days. 

“These data suggest that our oral COVID-19 therapy can be an important and effective tool in our continued battle against this devastating virus and current variants of concern, including the highly transmissible Omicron,” Pfizer’s chief scientific officer Mikael Dolsten said. “We will continue to monitor the treatment’s activity in real-world settings and believe that these in vitro findings will continue to be validated.”

As previously reported by Human Events News, the FDA in December authorized the Pfizer pill for emergency use. 

Paxlovid will be prescribed for use in adults and children over the age of 12 with mild to moderate sickness who are at risk for severe disease or hospitalization. 

N/A by N/A is licensed under N/A


View All

Parents Say NYC Children Are Seeking Therapy to Cope With Crime, Vagrants

In some cases, it has gotten to the point where kids don’t want to go outside....

Obama's Secret Service Detail Parks in Handicapped Spot for Two Hours as He Dines in Fancy LA Restaurant

The large, unmarked vehicle was spotted backing into the parking space near the entrance of the trend...

WATCH: Jen Psaki Warns that Dems 'Will Lose' if Election Is Referendum on Biden

'If it is a referendum on the president, they will lose and they know that.'...

WATCH: Rand Paul tells Jack Posobiec about his call to investigate Fauci and the origins of Covid

On the origins of Covid, Paul said, "I think by the time we're done with the investigation, and by th...

© 2022 Human Events, Privacy Policy